Montefiore Investment has entered into exclusive negotiations to take Generix Group private through a public tender offer. The transaction is structured via a new acquisition holding company, New Gen, in partnership with the historical reference shareholder Pléiade Investissement (which has held a stake since 2002) and the company's management. The strategic rationale for the deal is to accelerate Generix's transition to a full SaaS model and drive its international expansion outside of its core French market. The transition will be accompanied by a leadership change, with Aïda Collette-Sène succeeding Jean-Charles Deconninck as head of the executive board. By delisting from Euronext (Compartment C), the company aims to pursue its long-term growth projects away from the short-term pressures of the public markets.

GENERIX GROUP, which reported an EBITDA margin of LOGIN in 2021, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN premium to the 13.0x average currently observed in the TMT (Tech, Media, Telecom) sector.

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.